BEGIN:VCALENDAR
VERSION:2.0
PRODID: -//Q4 Inc.//EN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER:MAILTO:info@redhillbio.com
DTSTART;TZID="America/New_York":20161006T083000
DTEND;TZID="America/New_York":20161006T083000
LOCATION:
UID:955d291b-8d3e-48a8-acb3-e7568335d60e
DTSTAMP:20260412T222714
SUMMARY:RedHill Biopharma - Progress Update on RHB-104 Phase III Crohn's Disease Program
DESCRIPTION: View More Information: https://www.redhillbio.com/investors/events-and-presentations/event-details/2016/RedHill-Biopharma---Progress-Update-on-RHB-104-Phase-III-Crohns-Disease-Program/default.aspx
URL;VALUE=URI:https://www.redhillbio.com/investors/events-and-presentations/event-details/2016/RedHill-Biopharma---Progress-Update-on-RHB-104-Phase-III-Crohns-Disease-Program/default.aspx
PRIORITY:5
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR